Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BASF AG
DescriptionStructurally enhanced omega-3 fatty acid
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Fatty acid/lipid
Latest Stage of DevelopmentPhase II
Standard IndicationDyslipidemia
Indication DetailsTreat combined dyslipidemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today